Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Shockwave C2 Aero Coronary IVL Catheter from Shockwave Medical

J&J launches Shockwave Medical’s next-generation coronary IVL catheter

The Shockwave C2 Aero Coronary IVL Catheter is based on years of user feedback. For example, it was built with improved deliverability and repositioning capabilities in mind.

SCAI is inviting younger female interventional cardiologists and fellows within five years of training to participate in the WONDER (Women Exposed to Occupational Doses of Radiation) study.

SCAI seeks female interventional cardiologists for radiation risk study

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

doctor wrong patient wrong-site surgery medical error malpractice mistake

FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

Thumbnail

FDA clears next-gen hybrid system for intravascular imaging

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Robocath acquired by Stereotaxis

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

Protaryx Transseptal Puncture Device

FDA clears next-gen device for left-heart access

Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.